Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases

In the past 17 years, three novel coronaviruses have caused severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and the coronavirus disease 2019 (COVID-19). As emerging infectious diseases, they were characterized by their novel pathogens and transmissibility without a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinling, Xia, Shuai, Wang, Qian, Xu, Wei, Li, Weihua, Lu, Lu, Jiang, Shibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311999/
https://www.ncbi.nlm.nih.gov/pubmed/32481690
http://dx.doi.org/10.3390/ijms21113843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311999/
https://www.ncbi.nlm.nih.gov/pubmed/32481690
http://dx.doi.org/10.3390/ijms21113843

Ejemplares similares